Fujian Shengdi Pharmaceutical Co., Ltd.

This early-stage study tested a new injectable drug called HRS-9057 to see if it is safe and can help reduce dangerous fluid buildup in people with heart failure. It compared the new injection to an existing pill (tolvaptan) in 24 patients who still had swelling and congestion de…

This early-stage study tested the safety and initial effectiveness of a new injection called HRS-7450 for people who recently had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The trial involved 64 participants who received the drug within 24 hours …

This large, completed study tested whether a new drug called HR20013 works better than a standard drug (palonosetron) at preventing nausea and vomiting in cancer patients receiving chemotherapy that has a moderate risk of causing these side effects. It involved 706 adults who wer…

This was an early safety study of a new experimental drug called HRS-7249, which is being developed to treat high cholesterol. Researchers gave single injections of the drug to 48 healthy volunteers to see how safe it was, how the body processed it, and if it affected cholesterol…